BioArctic AB (STU:B9A) E10: €0.19 (As of Mar. 2026)


STU:B9A BioArctic AB STU:B9A
76 GF Score
Price €29.80
GF Value €44.01
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is BioArctic AB E10?

BioArctic AB STU:B9A -0.40% 76 E10 is €0.19 as of Mar. 2026. GuruFocus rates STU:B9A with a GF Score™ of 76/100 and a GF Value™ of €44.01 (Significantly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BioArctic AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.222. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.19 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-04), BioArctic AB's current stock price is €29.80. BioArctic AB's E10 for the quarter that ended in Mar. 2026 was €0.19. BioArctic AB's Shiller PE Ratio of today is 156.84.

During the past 11 years, the highest Shiller PE Ratio of BioArctic AB was 173.60. The lowest was 147.49. And the median was 158.33.


BioArctic AB  (STU:B9A) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BioArctic AB's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=29.80/0.19
=156.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Shiller P/E Ratio of BioArctic AB was 173.60. The lowest was 147.49. And the median was 158.33.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BioArctic AB E10 Related Terms


BioArctic AB E10 Historical Data

* Premium members only.

The historical data trend for BioArctic AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioArctic AB E10 Chart

BioArctic AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BioArctic AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.19

STU:B9A vs VRTX, REGN, ALNY: E10 Comparison

For the Biotechnology subindustry, BioArctic AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioArctic AB Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioArctic AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BioArctic AB's Shiller PE Ratio falls into.


STU:B9A
76GF Score
BioArctic AB STU:B9A
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioArctic AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioArctic AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.222/133.5600*133.5600
=0.222

Current CPI (Mar. 2026) = 133.5600.

BioArctic AB Quarterly Data

per share eps CPI Adj_EPS
201512 0.000 100.276 0.000
201609 -0.009 101.138 -0.012
201612 0.088 102.022 0.115
201703 0.001 102.022 0.001
201706 0.003 102.752 0.004
201709 0.000 103.279 0.000
201712 0.014 103.793 0.018
201803 0.018 103.962 0.023
201806 0.006 104.875 0.008
201809 0.028 105.679 0.035
201812 0.370 105.912 0.467
201903 0.014 105.886 0.018
201906 0.107 106.742 0.134
201909 -0.008 107.214 -0.010
201912 -0.019 107.766 -0.024
202003 0.004 106.563 0.005
202006 -0.041 107.498 -0.051
202009 -0.022 107.635 -0.027
202012 -0.015 108.296 -0.018
202103 -0.032 108.360 -0.039
202106 -0.039 108.928 -0.048
202109 -0.042 110.338 -0.051
202112 -0.020 112.486 -0.024
202203 -0.047 114.825 -0.055
202206 -0.049 118.384 -0.055
202209 0.143 122.296 0.156
202212 -0.060 126.365 -0.063
202303 0.295 127.042 0.310
202306 -0.099 129.407 -0.102
202309 0.119 130.224 0.122
202312 -0.089 131.912 -0.090
202403 -0.057 132.205 -0.058
202406 -0.068 132.716 -0.068
202409 -0.019 132.304 -0.019
202412 -0.031 132.987 -0.031
202503 1.053 132.825 1.059
202506 0.099 133.699 0.099
202509 -0.089 133.480 -0.089
202512 -0.009 133.390 -0.009
202603 0.222 133.560 0.222

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.19 mean?
BioArctic AB (STU:B9A) has a E10 of €0.19 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioArctic AB and its competitors.
Is BioArctic AB's E10 too high?
BioArctic AB's current E10 is €0.19. Overall, BioArctic AB has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioArctic AB's E10 compare to VRTX and REGN?
BioArctic AB's E10 of €0.19 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on BioArctic AB and its competitors. BioArctic AB's current E10 is €0.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioArctic AB stock overvalued right now?
Based on GuruFocus' analysis, BioArctic AB (STU:B9A) is currently considered Significantly Undervalued. The stock's GF Value™ is €44.01, compared to a current price of €29.80 — trading 32.3% below its estimated fair value. The current E10 is €0.19. BioArctic AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For BioArctic AB (STU:B9A), the current E10 is €0.19 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioArctic AB (STU:B9A) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of €29.80 is trading 32.3% below its estimated GF Value™ of €44.01. GuruFocus considers BioArctic AB to be Significantly Undervalued.

Key valuation signals for STU:B9A:

  • E10: €0.19
  • GF Value™: €44.01 vs. price of €29.80 (32.3% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the STU:B9A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
76GF Score

Get the complete analysis for STU:B9A

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.80
Price
€44.01
GF Value